Iron therapy in anaemia drugs used and patient numbers

Q1. How many patients have been treated in the last 6 months (for any disease) with the following products:

Feraccru (ferric maltol capsules)
Ferinject (ferric carboxymaltose injection/infusion)
Monofer (ferric derisomaltose injection)
Cosmofer (iron dextran injection)
Venofer (iron sucrose injection)
Any of the above 5 products

Please see below data held by the Trust’s Pharmacy department. If the drug is not listed it is because it has not been issued in the past 6 months.

Issue to patients

FERRIC CARBOXYMALTOSE 1000 mg in 20ml Injection
Number of patients: 785

Issue to ward – no patient details available.

IRON ISOMALTOSIDE (DIAFER) (ferric derisomaltose) 100 mg in 2ml Solution for Injection
Sum of net quantity in dose units: 1225

Q2. For the patients treated in the last 6 months with any of products listed in Q1, how many patients were diagnosed (at any point in the last 12 months) with the following:

Chronic Kidney Disease (ICD10 code – N.18)
Heart Failure (ICD10 code – I.50)
Inflammatory Bowel Disease (ICD10 codes – K.50 to K.52)
Malignant neoplasms (ICD10 codes C.00 to c.96)
Post-Partum Haemorrhage (ICD10 code O.72)

The Trust regret we are unable to answer this question as data relating to which patients were treated with which products is not collated by the Trust. The Trust’s Pharmacy department can advise products issued from their department, but they do not record the indication for its use.

The Trust’s BI department can advise numbers of patients admitted with the above conditions, however, the patient’s treatment is not recorded alongside this data, nor is the date of initial diagnosis. Please see below patient admission data for information.

Chronic Kidney Disease
Number of patients: 2379

Heart Failure
Number of patients: 2471

Inflammatory Bowel Disease
Number of patients:1466

Malignant neoplasms
Number of patients: 6899

Post-Partum Haemorrhage
Number of patients: 1439

Grand Total
Number of patients: 14654

Q3. For the patients treated in the last 6 months with any of products listed in Q1, how many patients undertook the following elective surgeries at any point in the last 12 months:

Primary Hip Replacement (OPCS codes W371, W381 and W941)
Hysterectomy (OPCS codes Q074 and Q075)
Colorectal Resection (OPCS codes H071, H0712, H073, H074, H333 and H336)
Coronary Artery Bypass Graft (OPCS code K453)
Cardiac Valve Surgery (OPCS codes K262 and K255)

As above, we regret this data is not collated by the Trust. Please see below the number of procedures undertaken in the last 12 months, but we cannot confirm whether or not they were being treated with the products listed in question 1.

Colorectal Resection
Number of patients: 68

Hysterectomy
Number of patients: 146

Coronary Artery Bypass Graft
Number of patients: 0

Primary Hip Replacement
Number of patients: 176

Grand Total
Number of patients: 390